Singapore — In a groundbreaking collaboration that took place on August 27th, the American Limb Preservation Society (ALPS) with its Diabetic Foot Conference (DFCon) partnered with the Society of Vascular and Endovascular Surgeons of Singapore (SVESS) to shine a spotlight on the critical issue of limb preservation. This joint effort marks a significant stride in raising global awareness about diabetic foot complications and advocating for advanced limb preservation techniques.
The annual conference of ALPS, DFCon, has a longstanding reputation for uniting healthcare professionals and researchers in the fight against diabetic foot-related challenges. By sharing pioneering research, cutting-edge technologies, and optimal practices, DFCon has consistently spearheaded enhanced patient outcomes and solutions for diabetic foot conditions.
The recent partnership saw ALPS/DFCon join forces with the eminent Society of Vascular and Endovascular Surgeons of Singapore (SVESS), to extend the scope and influence of their missions. By combining the expertise of ALPS/DFCon with the regional insights of SVESS, this collaboration has created a dynamic platform for addressing limb preservation from a comprehensive global perspective.
Limb preservation remains a critical concern within the diabetic community, given the heightened risk of foot ulcers and related complications among individuals with diabetes. The collective strength of ALPS/DFCon and SVESS has illuminated preventive measures, innovative treatments, and multidisciplinary strategies that hold promise for enhancing limb preservation outcomes.
ALPS founding president, Prof. David Armstrong, expressed enthusiasm about the collaboration, stating, “Our partnership with SVESS has taken the ALPS/DFCon mission to a global scale. The imperative for limb preservation knows no borders, and through this alliance, we have explored inventive solutions and catalyzed transformative change for individuals grappling with diabetes”.
The Education Chair of SVESS, renowned vascular surgeon Dr. Steven Kum, was equally enthusiastic, “We are thrilled to embark on this collaboration with DFCon. This will elevate the standard of care and education with an engaging program that focuses on not only the practice but the science of care for the Diabetic foot”.
The groundbreaking collaboration between DFCon and SVESS underscores their shared dedication to propelling the field of diabetic foot care and limb preservation forward. By aligning their efforts, these organizations are poised to make substantial contributions to improved patient outcomes, heightened awareness, and elevated care for those impacted by diabetic foot conditions across the globe.
For more information about the recent collaboration between DFCon and SVESS, as well as updates on upcoming events, please visit https://themeetinglab.eventsair.com/svess/.
For more information about ALPS or DFCon, please contact Annkathrin Mathe (American Limb Preservation Society) at am@cap-partner.eu.
About ALPS
The American Limb Preservation Society (ALPS) is a renowned organization dedicated to preserving limbs for individuals at risk of limb-threatening conditions. ALPS brings together medical professionals, researchers, and stakeholders to advance the understanding and treatment of limb preservation, particularly in the context of diabetes and related complications, to achieve its vision of ending preventable amputations over the next generation.
About DFCon
DFCon, the International Diabetic Foot Conference and the annual conference of ALPS, serves as a global hub for addressing the complexities posed by diabetic foot complications. With a focus on cutting-edge research, clinical innovations, and interdisciplinary collaboration, DFCon plays a pivotal role in elevating patient outcomes and advancing the field of diabetic foot care.
About SVESS
The Society of Vascular and Endovascular Surgeons of Singapore (SVESS) stands as a leading professional entity dedicated to championing excellence in vascular and endovascular surgery. Through education, collaborative efforts, and research initiatives, SVESS is committed to raising the standards of vascular care and contributing to positive patient outcomes.